What Researchers Did
Researchers conducted a systematic review and meta-analysis of 14 controlled clinical trials involving 768 participants to evaluate the efficacy of hyperbaric oxygen therapy for diabetic foot ulcers.
What They Found
Hyperbaric oxygen therapy significantly improved complete healing of diabetic foot ulcers (OR = 0.29; 95% CI 0.14-0.61) and reduced major amputations (RR = 0.60; 95% CI 0.39-0.92). However, it did not affect minor amputations, ulcer area reduction, or mortality rates, and the standard treatment group reported more adverse events (RR = 1.68; 95% CI 1.07-2.65).
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers may benefit from hyperbaric oxygen therapy as an additional treatment to promote complete healing. This therapy could also help reduce the risk of major amputations, potentially improving patient outcomes.
Canadian Relevance
This study did not include any Canadian participants or researchers, and therefore has no direct Canadian connection.
Study Limitations
The study noted significant heterogeneity among the included trials, particularly regarding complete healing and minor amputations, which may impact the generalizability of the findings.